About Us

Harry is a seasoned veteran of the Pharmaceutical & Biotech Industry with over 33 years of experience. In 2002 he founded Insight Strategy Advisors (ISA), a consulting firm that quickly became a leader in commercialization strategy for the industry’s top companies. ISA’s success led to its acquisition by Blackstone-backed Precision Medicine Group in December 2017

His extensive pricing, commercialization, and distribution expertise has been called upon by the Senate Permanent Sub Committee on Investigations and noted in their Report on Drug Pricing.  Harry continues to advise industry and private equity executives as well as mentor young professionals interested in life sciences and entrepreneurship.

Biostream Technologies is focused on developing interactive and evidence-based adjunctive therapies to help therapists and teachers help children live well with autism.  The current products are designed to improve eye contact, visual behavior, attention, and emotion recognition.

Harry is the proud parent of a child with autism and is committed to advancing technologies to assist the passionate, committed, and tenacious therapist and special education communities.        

Harry received his BA in Economics from Davidson College.